Studying Faster Ventilator
Independence

Lungpacer Medical is currently enrolling patients in a pivotal clinical study, RESCUE 3. The study will help evaluate the safety and efficacy of the device to seek regulatory approval of the AeroPace System.

research-img
0
Scientific Abstracts/
Presentations
0
Peer Reviewed
Publications
0 +
Patients
Studied

Outcomes from a Lungpacer Clinical Study Showed

Lungpacer strengthened the diaphragm and improved lung function

246 %
Stronger
Diaphragm*(MIP)
128 %
Improved
Lung Function*(RSBI)

Positive trending clinical outcomes

7.4 %
Increase in
Ventilator Weaning*
7.9 %
Greater
Survival*
1.4 Days
Less on a Ventilator*

These results from a randomized, controlled trial compared patients treated with Lungpacer therapy to patients treated with the standard of care. Improvement was statistically significant at p<0.05 for MIP and RSBI; p>0.05 for clinical trends. The rate of serious adverse events was the same between both groups.  No unanticipated adverse device effects.  Device safety events were those commonly reported for central venous catheters.

Published Research